Some reports indicate that chemotherapeutic agents like 5-fluorouracil, oxaliplatin, and irinotecan (FOLFIRINOX) may be beneficial when used in conjunction with vascular endothelial growth factor inhibitors, such as bevacizumab, for treating cardiac tumors [7]. This evidence concerns the gene VEGFA and heart neoplasm.